profits
AstraZeneca Q1 earnings down 12%; maintains FY view
April 29, 2016Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Q!, earnings, outlook, profits, q, results
UK drugmaker AstraZeneca (LSE: AZN) on Friday reported a 12% drop in first-quarter earnings and said it plans to streamline …
Revenues down at MSD
February 4, 2016Sales and Marketing MSD, financial performance, profits, revenue, sales
MSD (Merck, Sharpe and Dohme) reported a mixed bag of financial figures today, as the company announced full-year 2015 revenues …
Pfizer revenues down, but above expectations
February 3, 2016Research and Development, Sales and Marketing Ian Read, Pfizer, financial results, income, profits, revenue, sales
Pfizer’s revenues took a hit from generic competition on former blockbusters, but the world’s new largest drugmaker still managed to …
Experts predict pharma sector to remain strong in 2016
December 21, 2015Sales and Marketing marketing, pharma, profits, sales
The year 2016 is set to see continued growth in research and development productivity, with significant new drug launches and …
Pharma company vows to plough profits back into R&D
November 30, 2015Sales and Marketing Australia, R&D, breast cancer, profits, sales, social enterprise
An Australian pharma company has adopted a social enterprise model in order to be able to donate 100% of its …
Sandoz and pharma division boost Novartis sales
July 21, 2015Sales and Marketing Alcon, Novartis, Sandoz, financial performance, financial results, income, profits, sales
Sales at Novartis reached $12.7 billion in the second quarter of 2015, while its operating income was $2.3 billion, the …
More changes at the top as AstraZeneca profits slip
November 1, 2013Sales and Marketing AstraZeneca, Crestor, Q3, profits
AstraZeneca’s third quarter revenues and profits fell below analysts’ expectations yesterday, but mitigated the news with the appointment of a …
Patients and profits – time for new priorities
July 29, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, McConaghie, andrew, pharma, profits
Pharmaceutical journalists don’t retire, they just go off patent. Well, I’m not retiring as such, but after ten years as …
